Xcout Intel
Amolyt Pharma
Amolyt Pharma is a clinical-stage biotechnology company specializing in the development of therapeutic peptides for rare endocrine diseases. Acquired by AstraZeneca, the company…
The full profile of Amolyt Pharma
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Amolyt Pharma →Already a subscriber? Sign in
Xcout Intel tracks Amolyt Pharma continuously — this profile deepens as new filings, funding, people and hiring data arrive.